COVID-19 control strategies and intervention effects in resource limited settings: A modeling study.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2021
Historique:
received: 29 04 2020
accepted: 18 05 2021
entrez: 2 6 2021
pubmed: 3 6 2021
medline: 29 6 2021
Statut: epublish

Résumé

Many countries with weaker health systems are struggling to put together a coherent strategy against the COVID-19 epidemic. We explored COVID-19 control strategies that could offer the greatest benefit in resource limited settings. Using an age-structured SEIR model, we explored the effects of COVID-19 control interventions-a lockdown, physical distancing measures, and active case finding (testing and isolation, contact tracing and quarantine)-implemented individually and in combination to control a hypothetical COVID-19 epidemic in Kathmandu (population 2.6 million), Nepal. A month-long lockdown will delay peak demand for hospital beds by 36 days, as compared to a base scenario of no intervention (peak demand at 108 days (IQR 97-119); a 2 month long lockdown will delay it by 74 days, without any difference in annual mortality, or healthcare demand volume. Year-long physical distancing measures will reduce peak demand to 36% (IQR 23%-46%) and annual morality to 67% (IQR 48%-77%) of base scenario. Following a month long lockdown with ongoing physical distancing measures and an active case finding intervention that detects 5% of the daily infection burden could reduce projected morality and peak demand by more than 99%. Limited resource settings are best served by a combination of early and aggressive case finding with ongoing physical distancing measures to control the COVID-19 epidemic. A lockdown may be helpful until combination interventions can be put in place but is unlikely to reduce annual mortality or healthcare demand.

Identifiants

pubmed: 34077483
doi: 10.1371/journal.pone.0252570
pii: PONE-D-20-12495
pmc: PMC8172066
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0252570

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

N Engl J Med. 2020 Mar 26;382(13):1199-1207
pubmed: 31995857
Epidemics. 2015 Mar;10:49-53
pubmed: 25843383
Science. 2020 May 8;368(6491):
pubmed: 32234805
Lancet Infect Dis. 2020 Jun;20(6):669-677
pubmed: 32240634
Lancet Infect Dis. 2020 May;20(5):553-558
pubmed: 32171059
Math Biosci Eng. 2013 Oct-Dec;10(5-6):1475-97
pubmed: 24245626
Lancet. 2020 Feb 15;395(10223):483
pubmed: 32061284
Lancet Public Health. 2020 May;5(5):e261-e270
pubmed: 32220655
JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
Lancet Infect Dis. 2020 Jun;20(6):678-688
pubmed: 32213332
BMC Med. 2009 Jun 22;7:30
pubmed: 19545404
Cochrane Database Syst Rev. 2020 Apr 8;4:CD013574
pubmed: 32267544
Lancet Glob Health. 2020 Apr;8(4):e488-e496
pubmed: 32119825
N Engl J Med. 2020 Apr 9;382(15):e28
pubmed: 32187460
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
PLoS One. 2017 Jun 14;12(6):e0179315
pubmed: 28614365
Lancet. 2020 Mar 28;395(10229):1015-1018
pubmed: 32197103
PLoS Comput Biol. 2017 Sep 12;13(9):e1005697
pubmed: 28898249
Lancet. 2020 Mar 7;395(10226):764-766
pubmed: 32105609
Nature. 2020 Mar 18;:
pubmed: 32203363
Lancet. 2020 Mar 14;395(10227):841-842
pubmed: 32113508
Nature. 2006 Jul 27;442(7101):448-52
pubmed: 16642006
Science. 2005 Aug 12;309(5737):1083-7
pubmed: 16079251
Nat Med. 2020 May;26(5):672-675
pubmed: 32296168
Proc Natl Acad Sci U S A. 2008 Mar 25;105(12):4639-44
pubmed: 18332436
JAMA. 2020 Apr 14;323(14):1341-1342
pubmed: 32125371

Auteurs

Kiran Raj Pandey (KR)

Hospital for Advanced Medicine and Surgery, Kathmandu, Nepal.

Anup Subedee (A)

Hospital for Advanced Medicine and Surgery, Kathmandu, Nepal.

Bishesh Khanal (B)

Nepal Applied Mathematics and Informatics Institute for Research (NAAMII), Kathmandu, Nepal.

Bhagawan Koirala (B)

Institute of Medicine, Tribhuvan University, Kathmandu, Nepal.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH